---
figid: PMC9094073__cdr-4-596.fig.1
figtitle: 'Targeting mTOR and eIF4E: a feasible scenario in ovarian cancer therapy'
organisms:
- NA
pmcid: PMC9094073
filename: cdr-4-596.fig.1.jpg
figlink: /pmc/articles/PMC9094073/figure/fig1/
number: F1
caption: PI3K/mTOR pathway and regulation of eIF4F complex. (A) PI3K and its downstream
  effectors AKT and mTOR are activated by many extracellular stimuli. The serine/threonine
  protein kinase mTOR forms, by association with several binding partners (mLST8,
  Raptor/Rictor, and mSIN1), 2 distinct complexes mTORC1 and mTORC2. mTORC2 activation
  leads to actin regulation and cytoskeleton organization, while mTORC1 allows the
  cap-dependent translation through the 4E-BPs phosphorylation, resulting in the dissociation
  of these proteins from eIF4E. PI3K pathway dysregulation results in an altered proliferation,
  carcinogenesis, and angiogenesis. (B) The cap-binding protein eIF4E is released
  by 4E-BPs as a result of its phosphorylation by mTORC1, allowing eIF4F complex formation
  and thus permitting translation of eIF4E-sensitive mRNAs.
papertitle: 'Targeting mTOR and eIF4E: a feasible scenario in ovarian cancer therapy.'
reftext: Alice Romagnoli, et al. Cancer Drug Resist. 2021;4(3):596-606.
year: '2021'
doi: 10.20517/cdr.2021.20
journal_title: Cancer Drug Resistance
journal_nlm_ta: Cancer Drug Resist
publisher_name: OAE Publishing Inc.
keywords: Ovarian cancer | targeted therapy | mTOR pathway | eIF4E | inhibitors
automl_pathway: 0.8742236
figid_alias: PMC9094073__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC9094073__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9094073__cdr-4-596.fig.1.html
  '@type': Dataset
  description: PI3K/mTOR pathway and regulation of eIF4F complex. (A) PI3K and its
    downstream effectors AKT and mTOR are activated by many extracellular stimuli.
    The serine/threonine protein kinase mTOR forms, by association with several binding
    partners (mLST8, Raptor/Rictor, and mSIN1), 2 distinct complexes mTORC1 and mTORC2.
    mTORC2 activation leads to actin regulation and cytoskeleton organization, while
    mTORC1 allows the cap-dependent translation through the 4E-BPs phosphorylation,
    resulting in the dissociation of these proteins from eIF4E. PI3K pathway dysregulation
    results in an altered proliferation, carcinogenesis, and angiogenesis. (B) The
    cap-binding protein eIF4E is released by 4E-BPs as a result of its phosphorylation
    by mTORC1, allowing eIF4F complex formation and thus permitting translation of
    eIF4E-sensitive mRNAs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mtor
  - Tor
  - rictor
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - ras
  - Ras64B
  - Ras85D
  - S6k
  - Akt
  - Crtc
  - raptor
  - Thor
  - gig
  - Tsc1
  - Rheb
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E1
  - eIF4E6
  - eIF4EHP
  - eIF4G2
  - eIF4G1
  - CG9932
  - eIF4A
  - CG7483
  - pAbp
  - 'Off'
  - 'On'
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - RPS6KB1
  - AKT1
  - AKT2
  - AKT3
  - RPTOR
  - TSC2
  - TSC1
  - CCL26
  - RHEB
  - RHEBP1
  - EIF4A2
  - EIF4E
  - EIF4G1
  - EIF4E2
  - EIF4E3
  - EIF4G2
  - EIF4G3
  - EIF4A1
  - EIF4A3
  - PABPC1
---
